WhitTier Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.86M Buy
81,997
+2
+0% +$117 0.1% 155
2025
Q4
$4.46M Sell
81,995
-3,847
-4% -$185K 0.09% 167
2025
Q3
$3.9M Sell
85,842
-2,053
-2% -$95.9K 0.08% 175
2025
Q2
$4.07M Sell
87,895
-33
-0% -$1.62K 0.09% 179
2025
Q1
$5.36M Buy
87,928
+1,124
+1% +$65.5K 0.14% 146
2024
Q4
$4.91M Buy
86,804
+829
+1% +$46.3K 0.12% 153
2024
Q3
$4.45M Sell
85,975
-5,685
-6% -$267K 0.11% 156
2024
Q2
$3.81M Buy
91,660
+1,984
+2% +$88.8K 0.11% 164
2024
Q1
$4.86M Sell
89,676
-2,030
-2% -$103K 0.14% 145
2023
Q4
$4.71M Sell
91,706
-2,666
-3% -$140K 0.15% 143
2023
Q3
$5.48M Sell
94,372
-3,694
-4% -$226K 0.19% 113
2023
Q2
$6.27M Buy
98,066
+1,131
+1% +$75.8K 0.21% 111
2023
Q1
$6.72M Sell
96,935
-1,830
-2% -$129K 0.25% 97
2022
Q4
$7.11M Sell
98,765
-257
-0.3% -$19.4K 0.28% 83
2022
Q3
$7.04M Sell
99,022
-901
-0.9% -$65.4K 0.3% 77
2022
Q2
$7.69M Sell
99,923
-1,536
-2% -$117K 0.32% 75
2022
Q1
$7.41M Buy
101,459
+795
+0.8% +$53.4K 0.27% 88
2021
Q4
$6.28M Sell
100,664
-6,309
-6% -$370K 0.23% 104
2021
Q3
$6.33M Sell
106,973
-886
-0.8% -$58.3K 0.26% 95
2021
Q2
$7.21M Sell
107,859
-487
-0.4% -$31.8K 0.3% 82
2021
Q1
$6.84M Buy
108,346
+809
+0.8% +$50.3K 0.31% 81
2020
Q4
$6.67M Sell
107,537
-1,773
-2% -$109K 0.33% 77
2020
Q3
$6.59M Sell
109,310
-205
-0.2% -$12.3K 0.38% 66
2020
Q2
$6.44M Sell
109,515
-14,251
-12% -$852K 0.41% 65
2020
Q1
$6.9M Sell
123,766
-6,985
-5% -$427K 0.53% 51
2019
Q4
$8.39M Buy
130,751
+15,968
+14% +$914K 0.54% 52
2019
Q3
$5.82M Sell
114,783
-1,519
-1% -$71.4K 0.41% 70
2019
Q2
$5.27M Sell
116,302
-7,412
-6% -$345K 0.38% 74
2019
Q1
$5.9M Sell
123,714
-902
-0.7% -$44.9K 0.44% 63
2018
Q4
$6.48M Sell
124,616
-14,816
-11% -$796K 0.54% 53
2018
Q3
$8.66M Sell
139,432
-847
-0.6% -$50.3K 0.63% 45
2018
Q2
$7.76M Buy
140,279
+2,053
+1% +$111K 0.61% 47
2018
Q1
$8.74M Buy
138,226
+7,697
+6% +$495K 0.71% 37
2017
Q4
$8M Buy
130,529
+7,214
+6% +$451K 0.68% 39
2017
Q3
$7.86M Buy
123,315
+7,114
+6% +$415K 0.73% 37
2017
Q2
$6.47M Buy
116,201
+1,598
+1% +$87K 0.63% 46
2017
Q1
$6.23M Sell
114,603
-8,049
-7% -$441K 0.62% 47
2016
Q4
$7.17M Buy
122,652
+11,603
+10% +$634K 0.76% 36
2016
Q3
$5.99M Buy
111,049
+250
+0.2% +$16.1K 0.68% 44
2016
Q2
$8.15M Sell
110,799
-670
-0.6% -$47.3K 0.93% 22
2016
Q1
$7.12M Sell
111,469
-2,345
-2% -$148K 0.83% 35
2015
Q4
$7.83M Buy
113,814
+7,519
+7% +$497K 0.92% 24
2015
Q3
$6.29M Sell
106,295
-331
-0.3% -$21K 0.77% 33
2015
Q2
$7.09M Sell
106,626
-2,372
-2% -$156K 0.79% 30
2015
Q1
$7.03M Sell
108,998
-192
-0.2% -$12K 0.78% 31
2014
Q4
$6.44M Buy
109,190
+1,000
+0.9% +$56.4K 0.72% 40
2014
Q3
$5.54M Sell
108,190
-2,488
-2% -$124K 0.64% 50
2014
Q2
$5.37M Sell
110,678
-4,295
-4% -$212K 0.6% 54
2014
Q1
$5.97M Sell
114,973
-1,779
-2% -$94.7K 0.7% 42
2013
Q4
$6.21M Sell
116,752
-4,125
-3% -$210K 0.75% 38
2013
Q3
$5.59M Sell
120,877
-2,900
-2% -$127K 0.75% 37
2013
Q2
$5.53M Buy
+123,777
New +$5.37M 0.8% 34

Other funds holding BMY

WhitTier Trust Company's BMY Position: Q1 2026 in Review

WhitTier Trust Company increased its Bristol-Myers Squibb (BMY) stake by 0% in Q1 2026, buying an estimated $117 and bringing the position to 81,997 shares worth $4.86M. The position accounts for 0.1% of the portfolio, ranked #155.

WhitTier Trust Company first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.74M in Q1 2018. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • WhitTier Trust Company held 81,997 shares of Bristol-Myers Squibb worth $4.86M as of Q1 2026.
  • WhitTier Trust Company bought 2 Bristol-Myers Squibb shares in Q1 2026, an estimated $117.
  • Bristol-Myers Squibb made up 0.1% of WhitTier Trust Company's portfolio in Q1 2026, its #155 holding.
  • WhitTier Trust Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • WhitTier Trust Company's Bristol-Myers Squibb position peaked at $8.74M in Q1 2018.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on WhitTier Trust Company's 13F filing for Q1 2026, filed 28 Apr 2026.